Anqi Zhu
Title
Cited by
Cited by
Year
Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences
A Zhu, JG Ibrahim, MI Love
Bioinformatics 35 (12), 2084-2092, 2019
3412019
Nonparametric expression analysis using inferential replicate counts
A Zhu, A Srivastava, JG Ibrahim, R Patro, MI Love
Nucleic Acids Research 47 (18), e105, 2019
202019
Incidence and time course of neutropenia in patients treated with rituximab‐based therapy for non‐malignant immune‐mediated hematologic diseases
LE Malpica Castillo, S Palmer, A Zhu, AM Deal, SL Chen, S Moll
American journal of hematology 95 (5), E117-E120, 2020
32020
Acute myeloid leukemia with co-mutated ASXL1 and SRSF2 exhibits monocytic differentiation and has a mutational profile overlapping with chronic myelomonocytic leukemia
SM Johnson, DR Richardson, J Galeotti, S Esparza, A Zhu, Y Fedoriw, ...
HemaSphere 3 (5), 2019
32019
A national cross-sectional survey of financial toxicity among bladder cancer patients
M Ehlers, M Bjurlin, J Gore, R Pruthi, G Narang, R Tan, M Nielsen, A Zhu, ...
Urologic Oncology: Seminars and Original Investigations 39 (1), 76. e1-76. e7, 2021
22021
MRLocus: identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity
A Zhu, N Matoba, EP Wilson, AL Tapia, Y Li, JG Ibrahim, JL Stein, MI Love
PLoS genetics 17 (4), e1009455, 2021
12021
Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
LM Garner, T Kline, J Miller, A Deal, A Zhu, MR Sketch, CC Coombs, ...
Journal of the Advanced Practitioner in Oncology 12 (1), 20, 2021
12021
Adherence to infectious disease screening and immunization guidelines when treating non‐malignant immune‐mediated hematologic disorders
LE Malpica‐Castillo, S Palmer, A Zhu, AM Deal, SL Chen, S Moll
American journal of hematology 95 (3), E72-E75, 2020
12020
A super‐combo‐drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy
A Zhu, D Zeng, L Shen, X Ning, L Li, P Zhang
Statistics in Medicine 39 (10), 1458-1472, 2020
12020
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia
AH Szeto, T Bucci, A Deal, A Zhu, M Ahmad, AS Cass, MR Sketch, ...
Annals of Pharmacotherapy, 10600280211044160, 2021
2021
Improving Postoperative Multidisciplinary Care Coordination for Patients with Gliomas
SK Daniel Zeitouni, Michael P. Catalino, Anqi Zhu
Journal of Oncology Navigation and Survivorship 11 (7), 2020
2020
Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia
B Muluneh, C Coombs, L Drawdy, T Kline, A Deal, A Zhu, J Miller, ...
LEUKEMIA & LYMPHOMA 61, 119-119, 2020
2020
Package ‘fishpond’
A Zhu, A Srivastava, J Ibrahim, R Patro, M Love, MM Love
2020
Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders
LE Malpica-Castillo, S Palmer, A Zhu, AM Deal, SL Chen, S Moll
American Journal of Hematology, 2019
2019
Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders
LEM Castillo, S Palmer, A Zhu, A Deal, SL Chen, S Moll
Blood 134, 792, 2019
2019
INNV-43. IMPROVING POST OPERATIVE FOLLOW-UP AND TIME TO ADJUVANT TREATMENT FOR HIGH GRADE GLIOMA
M Catalino, D Zeitouni, S Henretty, A Zhu, S Khagi
Neuro-Oncology 21 (Supplement_6), vi139, 2019
2019
Estimating causal log-odds ratio using the case-control sample and its application in the pharmaco-epidemiology study
A Zhu, D Zeng, P Zhang, L Li
Statistical methods in medical research 28 (7), 2165-2178, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–17